Sonic Healthcare (OTCMKTS:SKHHY – Get Free Report) was downgraded by research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.
Sonic Healthcare Stock Performance
OTCMKTS:SKHHY opened at $14.34 on Wednesday. Sonic Healthcare has a 52 week low of $12.94 and a 52 week high of $19.25. The firm has a 50-day moving average price of $14.11 and a two-hundred day moving average price of $14.72. The company has a current ratio of 1.01, a quick ratio of 0.90 and a debt-to-equity ratio of 0.59.
Sonic Healthcare Company Profile
Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.
Further Reading
- Five stocks we like better than Sonic Healthcare
- Microsoft Earnings Are Coming—But Azure and CapEx Will Decide the Reaction
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
